This site is intended for healthcare professionals only
LoginRegister

Cipla liquidates wholly owned subsidiary as part of internal restructuring

Ruchika SharmaWritten by Ruchika Sharma   |  
Cipla liquidates wholly owned subsidiary as part of internal restructuring
  • whatsapp
  • Telegram

New Delhi: Drug major Cipla on Saturday said it has voluntarily liquidated a wholly-owned step-down subsidiary.

This liquidation was a part of internal reorganisation and it will not affect performance or revenue of the company, Cipla said in a BSE filing.

Read also: Cipla bags USFDA nod for Sumatriptan Nasal Spray to treat migraine

"Cipla (UK) Ltd, a wholly owned subsidiary of Cipla (EU) Ltd and a wholly -owned step down subsidiary of the company, has been voluntarily liquidated with effect from March 5, 2021," the Mumbai-based drug firm said.

Read also: Cipla Gulf expands partnership with Alvotech for commercialization of 4 biosimilar medicines in Australia, New Zealand



ciplacipla newsliquidationinternal reorganisation
Source : PTI
Ruchika Sharma
Ruchika Sharma

    Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

    Show Full Article
    Next Story
    X